Cyclerion Therapeutics Inc (CYCN)

Mar 18, 2025

Dementia Market Expected to Experience Major Growth by 2032, According to DelveInsight | Charsire Biotech Corp, ProNeurogen Therapeutics, Resverlogix, Cyclerion Therapeutics, CSPC-NBP - Barchart

Mar 18, 2025

Feb 16, 2025

Top Gainers Today: Reborn Coffee (REBN) Leads with a 65% Surge, Cyclerion (CYCN) and Signing Day Sports (SGN) Follow – market - HPBL

Feb 16, 2025

Feb 05, 2025

3 US Penny Stocks With Market Caps Over $10M To Consider - Simply Wall St

Feb 05, 2025

Feb 05, 2025

Cyclerion Therapeutics Inc (NASDAQ: CYCN) Is The Number One Stock Currently Moving. - Stocks Register

Feb 05, 2025

Feb 05, 2025

Market Recap Check: Cyclerion Therapeutics Inc (CYCN)’s Negative Finish at 4.19, Up/Down -21.24 - The Dwinnex

Feb 05, 2025

Feb 04, 2025

Small Cap Stocks To ConsiderFebruary 02nd - MarketBeat

Feb 04, 2025

Feb 04, 2025

Cyclerion Therapeutics announces mixed shelf offering - MSN

Feb 04, 2025

Feb 04, 2025

Cyclerion Therapeutics Inc’s Bumpy Road: Analyzing the 52-Week Range and Future Prospects - The InvestChronicle

Feb 04, 2025

Feb 04, 2025

Check out these key findings about Cyclerion Therapeutics Inc (CYCN) - SETE News

Feb 04, 2025

Feb 04, 2025

3 Penny Stocks to Watch Now, 2/4/25 - TipRanks

Feb 04, 2025

Feb 03, 2025

A company insider recently sold 357,880 shares of Cyclerion Therapeutics Inc [CYCN]. Should You also Consider to Sale? – Knox Daily - Knox Daily

Feb 03, 2025

Feb 03, 2025

Analyzing CYCN’s current quarter earnings projections - US Post News

Feb 03, 2025

Feb 03, 2025

Biotech Alert: Searches spiking for these stocks today - TipRanks

Feb 03, 2025

Feb 01, 2025

Stock summary: Cyclerion Therapeutics surged by 41.01% over the past five days - Business Upturn

Feb 01, 2025

Jan 31, 2025

Stock market today: Signing Day Sports +62.89%, Cyclerion Therapeutics +57.43% among top gainers in early trading - Business Upturn

Jan 31, 2025

Jan 31, 2025

Top Premarket Gainers -January 31, 2025 at 07:32 am EST - Marketscreener.com

Jan 31, 2025

Jan 31, 2025

Stock market today: Perfect Moment posted rise of 89.86% whereas Enveric Biosciences saw fall of 45.64% in early trading - Business Upturn

Jan 31, 2025

Jan 08, 2025

Cyclerion Therapeutics (NASDAQ:CYCN) Shares Up 3.5% – Time to Buy? - Defense World

Jan 08, 2025

Jan 03, 2025

Looking Into Cyclerion Therapeutics's Recent Short Interest - Benzinga

Jan 03, 2025

Dec 23, 2024

Extended Session Gains Propel Cyclerion (CYCN) Amid Revenue Progress - Stocks Telegraph

Dec 23, 2024

Dec 19, 2024

Cyclerion Therapeutics (NASDAQ: CYCN) Amends License Agreement with Akebia Therapeutics and Generates Revenues for GrowthOn December 17, 2024, Cyclerion Therapeutics, Inc. filed an 8-K SEC Filing which detailed significant developments in its b - Defense World

Dec 19, 2024

Dec 17, 2024

Cyclerion advances growth strategy with new agreements - Investing.com

Dec 17, 2024

Dec 17, 2024

Cyclerion Therapeutics Secures Funding and Expands CNS Focus - TipRanks

Dec 17, 2024

Dec 17, 2024

Cyclerion advances growth strategy with new agreements By Investing.com - Investing.com UK

Dec 17, 2024

Dec 17, 2024

Cyclerion’s sGC Stimulator Portfolio Generates Revenues to Enable Company Growth - GlobeNewswire

Dec 17, 2024